Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic

This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti–vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods.

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Ophthalmol
Autori principali: Billioti de Gage, Sophie, Drouin, Jérôme, Desplas, David, Cuenot, François, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2020
Soggetti:
Research Letter
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7747036/
https://ncbi.nlm.nih.gov/pubmed/33331873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2020.5594
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi